[1]
Abu-Arefeh I., Russel G.: Prevalence of headache and migraine in
schoolchildren. BMJ 1994; 309: 765-769.
[2]
Heinrich M., Morris L., Kroner-Herwig B.: Self-report of headache
in children and adolescents in Germany: possibilities and confines of
questionnaire data for headache classification. Cephalalgia 2009; 29:
864-872.
[3]
Cutrer F., Michael MD.: Pathophysiology of migraine. Seminars in
Neurology. Headache 2010; 30: 120-130.
[4]
Welch K.M.A.: Contemporary concepts of migraine pathogenesis.
Neurology 2003; 61 (Suppl 4): S2-S8.
[5]
Welch K.M.A., Cutrerer FM., Goadsby P.J.: Migraine pathogenesis. Neural
and vascular mechanisms. Neurology 2003; 60 (Suppl 2): S9-S14.
[6]
Gruber ., Bernecker C., Pailer S. et al. Lipid profile in normal weight
migraineurs - evidence for cardiovascular risk. Eur J Neurol 2010; 17:
419-425.
[7]
Kemper R.H.A., Meijler W.J., Korf J., Ter Horst G.J.: Migraine and
function of the immune system: a meta-analysis of clinical literature
published between 1966 and 1999. Cephalalgia 2001; 21: 549-557.
[8]
Ambrosini A., Schoenen J.: The electrophysiology of migraine. Curr Opin
Neurol 2003; 16: 327-331.
[9]
Magis D., Ambrosini A., Bendtsen L. et al. Evaluation and proposal
for optymalisation of neurophysiological tests in migraine: Part 1 -
electrophysiological tests. Cephalalgia 2007; 27: 1323-1338.
[10]
Boćkowski L., Sobaniec W., Kułak W., Śmigielska-Kuzia J.: Serum and
intraerythrocyte antioxidant enzymes and lipid peroxides in children with
migraine. Pharmacol Reports 2008; 50: 542 - 548.
[11]
Bianchi A., Salomone S., Caracci F. et al.: Role of magnesium, coenzyme
Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitamin Horm
2004; 69: 297-312.
[12]
Boćkowski L.: The role of dietary factors in migraine headaches. [in:]
Zgorzalewicz-Stachowiak M.: The problems in diagnosis and treatment
of headache in children and adolescents. [in Polish] BiFolium, Lublin
2009: 95-108.
[13]
Boćkowski L., Sobaniec W., Kułak W.: Treatment of migraine in children.
[in Polish] Klinika Pediatryczna 2010 [in press]
[14]
Ciancarelli I., Tozzi-Ciancarelli M.G., Di Massmo C. et al.: Flunarizine
efects on oxidative stress in migraine patients. Cephalalgia 2004; 24:
528-532.
[15]
Boćkowski L., Sobaniec W., Żelazowska-Rutkowska B.: Proinflammatory
plasma cytokines in children with migraine. Pediatr Neurol 2009; 41: 17-21.
[16]
Boćkowski L., Sobaniec W., Żelazowska-Rutkowska B. et al.: Anti-
inflammatory plasma cytokines in children and adolescents with migraine
and tension-type headache. Pharmacol Reports 2010; 62: 287-291.
[17]
Boćkowski L., Sobaniec W., Śmigielska-Kuzia J. et al.: The pattern-
reversal visual evoked potentials in children with migraine with aura and
without aura. Rocz Akad Med. Bialymst 2003; 48: 154 -157.
[18]
Boćkowski L., Sobaniec W., Sołowiej E., Śmigielska-Kuzia J.: Auditory
cognitive event-related potentials in migraine with aura and without aura
in children and adolescents. [in Polish] Neurol Neurochir Pol 2004; 38:
9-14.
[19]
Boćkowski L., Śmigielska-Kuzia J., Sobaniec W., Sendrowski K.: Cortical
evoked potentials in children with migraine with aura and without aura.
Adv Med Sci 2010 [in press]
[20]
Boćkowski L., Sobaniec W., Śmigielska-Kuzia J. et al.: The qualitative
and quantitative EEG analysis in children and adolescents with migraine
and tension - type headaches. [in:] Zgorzalewicz-Stachowiak M. The
problems in diagnosis and treatment of headache in children and
adolescents. [in Polish] BiFolium, Lublin 2009: 83-93.
[21]
Boćkowski L., Śmigielska-Kuzia J., Sobaniec W., Sendrowski K.:
Evaluation of EEG abnormalities in children with migraine. J Ped Neurol
2010 [in Press]
[22]
Śmigielska-Kuzia J., Sobaniec W., Kułak W., Boćkowski L.: Assessment
of efficacy of piracetam in comparison with flunarizine in the treatment
of migraine and tension-type headaches in children. [in Polish] Neurol
Dziec 2002, 11(21): 45 - 58.